Literature DB >> 9926737

Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.

K A Woeber1, I Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9926737      PMCID： PMC1305436     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  6 in total

1.  Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism.

Authors:  T Self; M Weisburst; E Wooten; A Straughn; J Oliver
Journal:  JAMA       Date:  1975-03-17       Impact factor: 56.272

2.  Enhancement of warfarin-induced hypoprothrombinemia by thyrotoxicosis.

Authors:  A G Vagenakis; R Cote; M E Miller; L E Braverman; F Stohlman
Journal:  Johns Hopkins Med J       Date:  1972-07

Review 3.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

4.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.

Authors:  L Bartalena; S Brogioni; L Grasso; F Bogazzi; A Burelli; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

Review 5.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

6.  Problems of anticoagulation with warfarin in hyperthyroidism.

Authors:  H A Kellett; J S Sawers; F E Boulton; S Cholerton; B K Park; A D Toft
Journal:  Q J Med       Date:  1986-01
  6 in total
  1 in total

1.  A population-based assessment of the drug interaction between levothyroxine and warfarin.

Authors:  D Pincus; T Gomes; C Hellings; H Zheng; J M Paterson; M M Mamdani; D N Juurlink
Journal:  Clin Pharmacol Ther       Date:  2012-10-24       Impact factor: 6.875
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.